Skeletal muscle contractility is important for locomotion and posture, activities performed by different myofiber types with distinct contractile and metabolic properties. Mitochondria serve a critical function in the maintenance of skeletal myofiber homeostasis and to adjust energy production to the demand. They do so by the oxidation of glucose-derived pyruvate and the β-oxidation of fatty acids generating an electrochemical proton gradient through the respiratory complexes of the electron transport chain, which can be used to drive the phosphorylation of ADP to ATP, a reaction called oxidative phosphorylation (OXPHOS). What determines mitochondrial content and function is not completely understood.

Nuclear receptors and their cofactors regulate metabolism in response to environmental signals and trigger homeostatic responses by coordinately regulating transcriptional networks. Previous studies have established that nuclear receptors, such as the Peroxisome Proliferator-Activated Receptor (Ppar)-β/δ, estrogen-related receptor-α and γ, along with co-regulators such as Ppar-γ coactivator-1 (Ppargc1)-α and Ppargc1-β, as well as the nuclear receptor co-repressor 1, among others, control muscle physiology by modulating mitochondrial biogenesis and function, fiber type determination and switch, as well as muscle vascularization ^[@R1]--[@R5]^. Ppargc1-α is a master driver of mitochondrial biogenesis and its over-expression in skeletal muscle resulted in increased mitochondrial number and function ^[@R1]^, whereas skeletal muscle Ppargc1-α-deficiency led to a reduced number of mitochondria and a marked reduction of muscle oxidative capacity ^[@R6],\ [@R7]^.

The nuclear receptor Rev-erb-α is expressed in tissues such as liver and adipose tissue ^[@R8]^, where it modulates lipid, bile acid and glucose metabolism ^[@R8]--[@R13]^. In addition, Rev-erb-α controls adipogenesis ^[@R14],\ [@R15]^ as well as the macrophage inflammatory response^[@R16]^. Rev-erb-α interacts with the nuclear receptor co-repressor 1 and chromatin modifiers, such as the histone deacetylase 3, to form a complex repressing target gene transcription ^[@R17]^. Remarkably, a Rev-erb-α/Ppargc1-α cross-talk pathway regulates heme synthesis in hepatic cells ^[@R18],\ [@R19]^. Whether Rev-erb-α interacts with Ppargc1-α in muscle and whether Reverb-α controls skeletal muscle oxidative capacity has not been investigated yet.

Here we report that Rev-erb-α-deficient mice display severely reduced running capacity due to compromised skeletal muscle oxidative capacity. This was accompanied by both reduced mitochondrial function and reduced mitochondria content associated with lower mitochondrial biogenesis. We further show that Rev-erb-α modulates Ppargc1-α expression and function by modulating adenosine monophosphate-activated protein kinase (Ampk)/sirtuin (Sirt)-1 signaling. Additionally, Rev-erb-α regulates the autophagy process by repressing genes involved in autophagosome formation and lysosomal degradation. These observations were reproduced in muscle cells upon Rev-erb-α silencing, while Rev-erb-α over-expression induced the opposite phenotype (i.e. improved mitochondrial respiration, up-regulation of mitochondrial biogenesis genes and repression of autophagy genes). Over-expression or pharmacological activation of Rev-erb-α profoundly improved running capacity and mitochondrial respiration in mice. Rev-erb-α thus emerges as a novel regulator of skeletal muscle oxidative capacity.

Results {#S1}
=======

Rev-erb-α^−/−^ mice display lower exercise capacity {#S2}
---------------------------------------------------

Rev-erb-α expression is significantly higher in oxidative compared to more glycolytic muscles ([Fig. 1a](#F1){ref-type="fig"}). Notably, its expression is higher in soleus and gastrocnemius muscle upon exercise training ([Fig. S1a](#SD1){ref-type="supplementary-material"}). Thus we explored whether Rev-erb-α plays a role in skeletal muscle oxidative capacity and exercise capacity. *Rev-erbα*--deficient (*Rev-erbα*^−/−^) mice exhibited markedly reduced spontaneous locomotor activity in a free wheel exercise compared to wild-type littermates ([Fig. 1b](#F1){ref-type="fig"}). We next assessed basal (VO~2b~) and maximal (VO~2max~) oxygen consumption, reflecting aerobic capacity, by submitting *Rev-erbα*^−/−^ mice to a forced, progressive treadmill exercise. VO~2b~ measured at rest was not significantly different between the two genotypes, whereas VO~2max~ measured at exhaustion was significantly lower in *Rev-erbα*^−/−^ mice ([Fig. 1c](#F1){ref-type="fig"}), resulting in a \>60% reduced aerobic capacity during exercise. In a standard endurance exercise test performed at 70% of their respective VO~2max~, 50% of *Rev-erbα*^−/−^ mice, compared to only 20% of the wild-type mice, stopped running within 50 min indicative of their inability to sustain a long-lasting exercise ([Fig. 1d](#F1){ref-type="fig"}). In this setting, *Rev-erbα*^−/−^ mice ran for a significantly shorter time and distance than their wild-type littermates ([Fig. 1e,f](#F1){ref-type="fig"}).

Rev-erb-α controls muscle mitochondrial content and function {#S3}
------------------------------------------------------------

Mitochondrial DNA content was \~40% lower in skeletal muscle from *Rev-erbα*^−/−^ mice compared to wild-type littermates ([Fig. 2a](#F2){ref-type="fig"}), suggesting a regulatory role of Rev-erb-α on skeletal muscle mitochondrial content. Accordingly, expression of genes encoding subunits of the mitochondrial electron transport respiratory chain, such as NADH dehydrogenase 1, a subunit of complex I, and cytochrome c oxidase -1 and 2, two subunits of complex IV, was lower in soleus and quadriceps muscles from *Rev-erbα*^−/−^ mice ([Fig. 2b](#F2){ref-type="fig"}, [S1b](#SD1){ref-type="supplementary-material"}). In addition, protein relative amounts of the mitochondrial oxidative phosphorylation complexes were lower in *Rev-erbα*^−/−^ compared to *Rev-erbα*^+/+^ muscle ([Fig. 2c](#F2){ref-type="fig"}, [S1c](#SD1){ref-type="supplementary-material"}). Moreover, glutamate-malate-stimulated (state 2) respiration was lower in isolated fibers from *Rev-erbα*^−/−^ vs. *Reverbα*^+/+^ muscle, in line with the reduced mitochondrial content ([Fig. 2d](#F2){ref-type="fig"}). Mitochondrial oxidative capacity was impaired in *Rev-erbα*-deficient muscle as attested by a marked reduction of ADP-driven glutamate-malate (state 3) respiration in saponin-permeabilized fibers isolated from *Rev-erbα*^−/−^ compared to wild-type mice ([Fig. 2d](#F2){ref-type="fig"}). The lower respiration upon addition of succinate and rotenone demonstrates a reduced capacity of the entire chain rather than a deficiency in a specific complex. This was further underscored by the significantly lower respiration when comparing equal amounts of isolated mitochondria ([Fig. 2e](#F2){ref-type="fig"}), illustrating not only a decreased mitochondrial content, but also lower respiratory chain function of isolated *Rev-erbα*^−/−^ compared to *Rev-erbα*^+/+^ mitochondria.

Although gene expression analysis of fiber type markers suggested a switch toward a more glycolytic profile (tropomyosin 3, a marker of oxidative type 1 fiber, myosin heavy chain IIa and IIx, markers of mostly oxidative fibers, are lower in Rev-erbα-deficient soleus and quadriceps muscles, (data not shown), specific type 1, type2a and 2b immunostaining did not reveal any significant changes between the two genotypes ([Fig. S1d](#SD1){ref-type="supplementary-material"}). In addition, *Myoglobin* gene expression and vascularization, assessed by CD31 immunostaining on soleus muscle sections, were similar between the two genotypes ([Fig. S5d,e](#SD1){ref-type="supplementary-material"}).

To study whether Rev-erb-α regulates mitochondrial function in a cell-autonomous manner, C2C12 muscle cells were stably infected with a Rev-erb-α coding retrovirus. MitoTracker green staining, a marker of mitochondria content, was induced upon Rev-erb-α over-expression in differentiated C2C12 myotubes ([Fig. 3a](#F3){ref-type="fig"}). Notably, the JC--1 red/green ratio, an indicator of membrane potential, was also increased by Rev-erb-α over-expression in C2C12 cells, suggesting increased mitochondrial activity ([Fig. 3b](#F3){ref-type="fig"}). Rev-erb-α expression enhanced the maximal respiratory capacity due to enhanced coupled ATP-producing oxidative phosphorylation as illustrated by higher state 3U respiration and respiratory control ratio (RCR, OXPHOS/Leak ratio), whereas the uncoupling proton leakage remained unchanged ([Fig. 3c](#F3){ref-type="fig"}). Conversely, *Rev-erbα* silencing substantially reduced mitochondrial respiration ([Fig. S2a](#SD1){ref-type="supplementary-material"}) as well as the quantity of total (green Mitotracker) and functional (red Mitotracker) mitochondria ([Fig. S2b](#SD1){ref-type="supplementary-material"}) in differentiated C2C12 cells. Analysis of mitochondrial fatty acid oxidation in permeabilized fibers of *Rev-erbα*-deficient muscle revealed compromised oxygen consumption in the presence of palmitoyl-L-carnitine/malate alone and in presence of ADP ([Fig. 2f](#F2){ref-type="fig"}). In parallel, the expression of genes encoding enzymes of fatty acid β--oxidation, notably carnitine palmitoyltransferase1B (Cpt1b), (very) long chain (Acadvl, Acadl) and short chain (Acads) acyl-CoA dehydrogenases, was lower in *Rev-erbα*^−/−^ vs *Reverbα*^+/+^ skeletal muscle ([Fig. 2g](#F2){ref-type="fig"}, [S3a](#SD1){ref-type="supplementary-material"}), whereas Rev-erb-α retrovirus infected C2C12 cells displayed a mirror phenotype (i.e. higher *Acadvl*, *Acadl* and *Acads* acyl-CoA dehydrogenase expression) compared to control-infected pBabe cells ([Fig. 3d](#F3){ref-type="fig"}). These results indicate that Rev-erb-α modulates fatty acid β--oxidation-driven generation of reducing equivalents to feed in the electron transport chain *in vitro* and *ex vivo* in skeletal muscle. Together these results demonstrate that Rev-erb-α regulates muscle cell mitochondrial content and function.

Electron microscopy analysis on muscle sections revealed a slight misalignment of Z lines, the presence of vacuolated fibers, and the presence of abnormal, swollen and less dense mitochondria in muscle sections from *Rev-erbα*^−/−^ mice, compared to wild-type littermates ([Fig. 2h](#F2){ref-type="fig"}, [S4](#SD1){ref-type="supplementary-material"}), revealing a severe skeletal muscle phenotype and mitochondrial dysfunction of *Rev-erbα*^−/−^ mice. The repair process, assessed by the presence of centro-cellular nuclei ([Fig. S5a](#SD1){ref-type="supplementary-material"} shows that the nuclei are localized at the periphery of the fibers, testifying the absence of regeneration) and the absence of change in the expression of Pax7 and Myf5 ([Fig. S5b](#SD1){ref-type="supplementary-material"}), was not different between *Rev-erbα*^−/−^ mice and wild-type littermates. In line, immunofluorescent staining of Pax7 indicates its localization at the boundary of the myofiber ([Fig. S5c](#SD1){ref-type="supplementary-material"}), implying the presence of quiescent satellite cells located on the border of myofibers, which are similar in the two genotypes.

Rev-erb-α increases skeletal muscle mitochondrial biogenesis {#S4}
------------------------------------------------------------

mRNA (−56%) and protein (−50%) concentrations of Ppargc1-α, which plays a pivotal role in mitochondrial biogenesis, were lower in soleus and quadriceps muscle from *Reverbα*−/− mice ([Fig. 4a](#F4){ref-type="fig"}, [S3b, S3d](#SD1){ref-type="supplementary-material"}). Consistently, the expression of mitochondrial transcription factor A (*Tfam*) and nuclear respiratory factor-1, genes involved in mitochondrial biogenesis, was lower in *Rev-erbα*^−/−^ mice ([Fig. 4b](#F4){ref-type="fig"}). By contrast, Rev-erb-α over-expression increased *Ppargc1α* and *Tfam* in C2C12 cells ([Fig. 4h](#F4){ref-type="fig"}).

As a functional reflection of impaired mitochondrial electron transport chain activity, ATP concentrations were severely reduced in *Rev-erbα*-deficient muscle ([Fig 4c](#F4){ref-type="fig"}). Ampk, a 'fuel gauge' activated by liver kinase B1 (Lkb1 also known as serine threonine/kinase 11 or Stk11) when the AMP/ATP ratio increases, induces Sirt1-dependent deacetylation of Ppargc1-α as well as the expression of nicotinamide phosphoribosyltransferase (Nampt), the rate-limiting enzyme in the synthesis of the Sirt1 cofactor NAD+, thus impacting on mitochondrial and lipid oxidation genes ^[@R20]^. Of note, *Stk11* gene expression ([Fig. 4d](#F4){ref-type="fig"}, [S3d](#SD1){ref-type="supplementary-material"}), Ampk phosphorylation ([Fig. 4e](#F4){ref-type="fig"}) and activity illustrated by the p--Acac/Acac (Acetyl-coenzyme A carboxylase) ratio ([Fig. S3c](#SD1){ref-type="supplementary-material"}), as well as *Nampt* gene expression ([Fig. 4f](#F4){ref-type="fig"}) were lower in *Rev-erbα*-deficient compared to *Rev-erbα*^+/+^ muscle. Concentrations of NAD+ and NADH, the reducing equivalent produced by fatty acid oxidation, were lower in skeletal muscle from *Rev-erbα*^−/−^ mice compared to their littermates ([Fig. 4f](#F4){ref-type="fig"}). Moreover, a significantly lower *Sirt1* expression was observed in skeletal muscle from *Rev-erbα*^−/−^ compared to *Rev-erbα*^+/+^ mice ([Fig. 4f](#F4){ref-type="fig"}, [S3d](#SD1){ref-type="supplementary-material"}), and blunted SIRT1 activity was attested by increased Ppargc1-α acetylation ([Fig. 4g](#F4){ref-type="fig"}). Conversely, *Sirt1* and *Nampt* expression was induced in Rev-erb-α over-expressing C2C12 cells ([Fig. 4h](#F4){ref-type="fig"}), accompanied by significantly improved mitochondrial respiration, an effect which was fully blocked by the addition of the C compound, an inhibitor of Ampk phosphorylation ([Fig. 4i](#F4){ref-type="fig"}). Consistently, siRNA knock-down of *Ampkα1* and *Ampkα2* prevented the increase in mitochondrial content upon Rev-erb-α over-expression ([Fig. 4j](#F4){ref-type="fig"}), whereas Ampk activation by AICAR increased mitochondrial number in sh*Rev-erbα* cells, but not to the same extent as in control cells ([Fig. S2c](#SD1){ref-type="supplementary-material"}). Together these data indicate that Rev-erb-α regulates skeletal muscle mitochondria biogenesis through modulation of the Stk11--Ampk--Sirt1--Ppargc1-α pathway.

*Rev-erb*α-deficiency induces skeletal muscle autophagy {#S5}
-------------------------------------------------------

We next explored whether Rev-erb-α also modulates mitochondria degradation. Autophagy is a process mediating the selective clearance of cytoplasmic components, such as damaged mitochondria, which could otherwise become deleterious. Autophagy is a self-digestion process occurring via the formation of a vesicle (nucleation) expanding to become an autophagosome which engulfs cellular components and directs them to the lysosome for degradation. Expression of the genes encoding Ulk1, a protein of the initiation complex implicated in vesicle formation, Beclin1, a protein of the nucleation complex, as well as autophagy related gene-5 and Bnip3, which are responsible for vesicle elongation and autophagosome formation, and the lysosomal enzymes cathepsin L and ATPase6v1b2 were higher in skeletal muscle of *Rev-erbα*^−/−^ compared to *Rev-erbα*^+/+^ mice ([Fig. 5a, 5b](#F5){ref-type="fig"}), and lower in Rev-erb-α infected C2C12 cells vs. control cells ([Fig. S6](#SD1){ref-type="supplementary-material"}). Rev-erb-α also regulated gene and protein expression of Parkin (also known as Park2), a protein specifically involved in mitochondrial clearance ^[@R21]^ ([Fig. 5b](#F5){ref-type="fig"}, [S6](#SD1){ref-type="supplementary-material"}). The functional increase of autophagy was illustrated by the maturation of microtubule-associated protein 1 light chain 3 alpha (Map1lc3a, also known as LC3) Map1lc3a--I into its lipidated form Map1lc3a--II, a marker of ongoing autophagy associated with the autophagosome membrane ([Fig. 5c](#F5){ref-type="fig"}). Moreover, treatment with the lysosome inhibitors bafilomycin and NH~4~Cl which block the fusion of the lysosome with mature autophagosomes which subsequently accumulate, increased Map1lc3a--II levels to a significantly lesser extent in Rev-erb-α over-expressing C2C12 cells compared to treated control (pBabe) cells ([Fig. 5d](#F5){ref-type="fig"}). This indicates that autophagy flux is decreased upon Rev-erb-α over-expression. Conversely, the number of mitochondria was lower upon *Rev-erbα* silencing in C2C12 cells and addition of the autophagy blockers 3-methyl adenine and chloroquine or the lysosome inhibitors bafilomycin and NH~4~Cl prevented this decrease ([Fig 5e](#F5){ref-type="fig"}), suggesting that *Rev-erbα* deficiency results in an increased autophagy flux, thus contributing to the lower mitochondria number.

To gain further mechanistic insight, the distribution of Rev-erb-α binding sites in the vicinity of autophagy genes, assessed using chromatin immunoprecipitation (ChIP)-sequencing data^[@R17]^, was examined and overlaid with epigenetic marks obtained in C2C12 myotubes ^[@R22]^, reasoning that intense transcriptional activity at these marks may increase the likelihood of Rev-erb-α binding to these locations. Primers for ChIP-qPCR targeting these regions were then designed to assess Rev-erb-α binding and changes in acetylation marks in Rev-erb-α-expressing C2C12 cells. An enrichment of Rev-erb-α binding in the regulatory regions of several autophagy genes was observed ([Fig 5f](#F5){ref-type="fig"}), which was associated with decreased H3K27 ([Fig 5g](#F5){ref-type="fig"}) and H3K9 ([Fig 5h](#F5){ref-type="fig"}) acetylation on these sites.

Rev-erb-α activation improves muscle mitochondrial function {#S6}
-----------------------------------------------------------

Next, we determined the effect of pharmacological activation of Rev-erb-α, by treating mice with the synthetic ligand SR9009 ^[@R12]^, on exercise capacity. Notably, in an endurance exercise test, mice treated with SR9009 ran significantly longer both in time and distance than vehicle-treated mice ([Fig. 6a](#F6){ref-type="fig"}). Moreover, incubation of C2C12 cells with two different agonists increased the number of total (Mitotracker Green) and active (Mitotracker red) mitochondria ([Fig. 6b](#F6){ref-type="fig"}). Finally, skeletal muscle-specific Rev-erb-α over-expression in mice significantly improved mitochondrial function as attested by a significant increase in glutamate-malate-stimulated and ADP-driven respiration in absence and presence of succinate of permeabilized fibers ([Fig. 6c](#F6){ref-type="fig"}). Together these data indicate that enhancement of Rev-erb-α expression and/or activity exerts beneficial direct effects on skeletal muscle to improve mitochondrial respiration and exercise capacity.

Discussion {#S7}
==========

Results from both gain- and loss-of-function experiments identify Rev-erb-α as a physiological regulator of muscle mitochondrial content and oxidative function. This is supported by the following observations. First, Rev-erb-α is preferentially expressed in more oxidative muscles, such as soleus muscle, and *Rev-erbα*-deficient mice display profoundly altered exercise capacity associated with a marked decrease of mitochondrial content and function, the presence of swollen mitochondria and abundant vacuoles within the fibers. Similar alterations were observed upon knock-down of *Rev-erbα* in differentiated C2C12 myotubes (lower mitochondrial content and impaired mitochondrial function). By contrast, pharmacological activation or skeletal muscle-specific Rev-erb-α over-expression *in vivo* and *in vitro* in C2C12 cells results in the opposite phenotype, highlighting that Rev-erb-α exerts a direct action on skeletal muscle cells. Second, our data indicate that Rev-erb-α controls mitochondrial biogenesis and respiration through the Stk11--Ampk--Sirt1--Ppargc1--α signaling pathway. Finally, we show that skeletal muscle Rev-erb-α regulates several genes involved in different steps of the autophagy process, including genes more specifically dedicated to the elimination of damaged mitochondria. Together these data support the concept that Rev-erb-α acts through a two-pronged mechanism implicating both biogenesis of new mitochondria and clearance of defective mitochondria.

The regulation of the Stk11--Ampk--Sirt1--Ppargc1-α pathway by Rev-erb-α provides a molecular mechanism whereby Rev-erb-α controls mitochondrial biogenesis and function. Ampk and Sirt1 are crucial in the metabolic flexibility that allows skeletal muscle to switch to lipid oxidation during fasting and exercise. Deficient Ampk activity in *Rev-erbα*^−/−^ mice is associated with impaired Sirt1-mediated Ppargc1-α deacetylation and ensuing attenuated induction of mitochondrial fatty acid oxidation gene expression and reduced exercise capacity ^[@R20],\ [@R23]^. Likewise, Ppargc1-α acetylation is higher and its expression diminishes in *Rev-erbα*-deficiency, which may contribute to the reduced number of mitochondria, lower expression of transcription factors important for mitochondrial function, such as Tfam, and altered electron transport chain activity. In addition, expression of genes encoding fatty acid β--oxidation enzymes as well as palmitate-induced mitochondrial respiration is compromised in the absence of Rev-erb-α. This is further supported by defective Ampk activation, reduced NAD+ concentrations together with markedly altered *Sirt1* and *Nampt* expression, testifying a marked de-activation of this pathway. Moreover, the observation that siRNA or C compound-mediated inhibition of Ampk activity blocks the stimulatory effect of Rev-erb-α over-expression on mitochondrial respiration, demonstrates that Rev-erb-α-mediated improvement of mitochondrial respiration requires active Ampk. Of note, Ampk phosphorylation is not induced even though ATP concentrations are low in *Rev-erbα*-deficient mice. Binding of AMP increases the ability of other kinases to phosphorylate and activate the Ampk-α subunit. Stk11 is a major upstream kinase expressed in skeletal muscle that phosphorylates and activates Ampk, and *Stk11*-deficiency results in blunted Ampk activation, decreases *Ppargc1α* expression together with reduced exercise capacity as well as compromised mitochondrial activity ^[@R24],\ [@R25]^, a phenotype similar to the one observed in the *Rev-erbα*-deficient mice. Our results also indicate that mitochondria are damaged and mitochondrial oxygen consumption is reduced in *Rev-erbα*^−/−^ muscle, whereas skeletal muscle-specific Rev-erb-α over-expression improves mitochondrial respiration. Moreover, treatment of mice with a synthetic Rev-erb-α agonist increases oxygen consumption ^[@R12]^. Notably, and in contrast to other transcriptional regulators, such as Ppar-β/δ ^2^ and Ppargc1-α^[@R1],\ [@R6]^, Rev-erb-α modulates skeletal muscle oxidative capacity without inducing a fiber type switch, suggesting a disconnection between both phenomena upon *Rev-erb*α-deficiency. Together these data support a prominent role for Rev-erb-α in skeletal muscle mitochondria function.

Autophagy is a dynamic self-digestion process that ensures the selective clearance of damaged organelles or aggregated macromolecules, a particularly important mechanism in differentiated cells such as myotubes ^[@R26]--[@R28]^. Our data demonstrate that Rev-erb-α exerts a tight control on this pathway by regulating several genes involved in vesicle nucleation and expansion, autophagosome formation as well as genes encoding lysosomal enzymatic activities. The conversion of Map1lc3a--I to Map1lc3a--II and its lipidation is a hallmark of autophagy ^[@R29]^. The maturation into Map1lc3a--II was elevated in the absence of Rev-erb-α, whereas autophagy flux is decreased by Rev-erbα over-expression. Of note, Rev-erb-α represses genes triggering mitophagy, such as Park2, a cytosolic E3 ubiquitin ligase that translocates to depolarized mitochondria to induce mitophagy, thereby maintaining a pool of functioning mitochondria and limiting oxidative damage ^[@R21]^. Likewise, Rev-erb-α down-regulates *Ulk*1, which not only participates in the initiation complex, but may also play an important role in triggering mitophagy ^[@R30]^. Ulk1--deficiency indeed results in accumulation of defective mitochondria in mature red blood cells ^[@R31]^. Finally, we demonstrate that autophagy blockade by autophagy or lysosome inhibitors reverses the effect of *Rev-erbα* knock-down on total mitochondria number. Autophagy is also a survival mechanism by which cells produce energy in times of nutrient paucity. One of the most potent inducers of autophagy is Ampk, which directly phosphorylates Ulk1 and, simultaneously, turns off mTORC1 signaling, an inhibitor of autophagy ^[@R26],\ [@R28],\ [@R32]^. However, neither Ampk (which is down-regulated in the absence of Rev-erb-α) nor Mtor, whose signaling is not regulated by Rev-erb-α (not shown), are likely to mediate Rev-erb-α's action on autophagy. Another potent autophagy inducer, Sirt1 ^[@R33]^, is also down-regulated in the absence of *Rev-erbα*, again excluding that Sirt1 plays a role in the observed phenotype. Together these data indicate that Rev-erb-α by-passes these regulators and represses autophagy genes directly likely by binding to the DNA in the regulatory regions of these genes. Indeed, our ChIP-qPCR data confirmed Rev-erb-α binding enrichment in the regulatory regions of autophagy genes. This is accompanied by a modification of epigenetic marks at these sites as indicated by decreased H3K27 and H3K9 acetylation, consistent with the repressive role of Rev-erb-α on gene transcription.

Rev-erb-α is a component of the biological clock, which allows synchronisation of internal rhythms to daily environmental cues ^[@R34]^. Skeletal muscle displays circadian rhythmicity of gene expression ^[@R35],\ [@R36]^ and the clock components Clock and Brain and muscle ARNT-like-1 have been shown to participate in the maintenance of skeletal muscle function ^[@R37]^. mRNA concentrations of the clock genes are altered in skeletal muscle from *Rev-erbα*^−/−^ mice ([Fig. S7a](#SD1){ref-type="supplementary-material"}) and Rev-erb-α over-expression in synchronized C2C12 cells leads to an altered circadian expression pattern of *Ppargc1*α ([Fig. S7b](#SD1){ref-type="supplementary-material"}). Pharmacological activation of Rev-erb-α alters the circadian rhythms of *Cpt1b* and *Ppargc1*α in skeletal muscle ^[@R12]^. Consequently, in addition to a direct action of Rev-erb-α on autophagy genes and mitochondrial biogenesis and function, disturbed circadian rhythmicity due to *Rev-erbα* deletion or over-expression may contribute to the observed phenotype.

In conclusion, Rev-erb-α is a major physiological regulator of mitochondrial content and oxidative function. Pharmacological activation of Rev-erb-α may be a promising approach for the treatment of skeletal muscle diseases with compromised exercise capacity.

ONLINE METHODS {#S8}
==============

Animal studies {#S9}
--------------

We used *Rev-erbα*-deficient mice^[@R39]^ and their wild-type littermates (*Rev-erbα*^+/+^ mice). Mice were housed in a 12 h/12 h light/dark cycle and allowed ad libitum access to food and water. They received a regular chow diet. Mice were sacrificed by cervical dislocation and skeletal muscles were snap-frozen in liquid nitrogen and stored at −80 °C until RNA and protein isolation and histological staining. *Rev-erbα*-deficiency in mice was verified by qPCR analysis of skeletal muscle gene expression of *Rev-erbα* and its known target gene *Bmal1* ([fig. S8a](#SD1){ref-type="supplementary-material"}).

Rev-erb-α over-expression: we cloned the coding sequence of Rev-erb-α in front of a MCK promoter allowing muscle-specific expression and introduced in a 1/2 AAV vector (Sirion Biotech, Germany). We injected 2.1 × 10^10^ infectious particles intra-muscularly in the tibialis anterior muscle using the tibialis anterior muscle of the contra-lateral limb as control. Pharmacological activation: SR9009 was administered i.p. at 100 mpk for 30 days as previously described ^[@R12]^.

Maximal exercise stress test and endurance capacity {#S10}
---------------------------------------------------

Two days before the experiment, mice were acclimatized to a single lane treadmill by performing a 10 m min^−1^ run. The day of the exercise stress test, mice were placed into the treadmill enclosed in a metabolic chamber connected to an oxygen (O~2~) sensor (Oxymax, Columbus Instruments, Columbus, OH). We measured basal oxygen consumption (VO~2b~) after a 30 min resting period; then, mice were encouraged to run on the treadmill at 10 m min^−1^ and 0% incline. Every 3 min, the treadmill speed was incremented by 4 m min^−1^ until the mice reached exhaustion in order to determine their maximal VO~2~ (VO~2~max). The speed at which VO~2~max was obtained was considered as the maximal running speed (Vmax). One week later, we tested the mice for their endurance capacity. After a 6 min run at 30% of their maximal running speed, the treadmill speed was set at 70% of the VO~2~max. The experiment was stopped once mice stayed for 5 continuous seconds on the electrical grid. Time to exhaustion and total running distance were determined.

Daily wheel running activity {#S11}
----------------------------

To record daily running wheel behavior, we placed the animals into individual cages containing running wheels for 3 weeks (Campden, Phymep, Paris). Wheel revolution was recorded daily during the last two weeks and averaged.

Training {#S12}
--------

We examined Rev-erb-α expression in control (untrained) and exercised mice. Mice were trained for 8 weeks, 5 days per week, 1 to 2 h per day starting at a speed of 8 m min^−1^ up to 16 m min^−1^ the last 4 weeks.

Animal care and use were performed according to approved institutional guidelines and all experimental procedures were approved by the relevant ethic committees (Comité d'éthique en expérimentation animale Nord-Pas-De-Calais and The Scripps Research Institute Florida Campus Institutional Animal Care and Use Committee). We used male mice for all experiments.

Cell culture {#S13}
------------

We cultured C2C12 myoblasts in Dulbecco modified Eagle's medium (DMEM; 4.5 g l^−1^ D-Glucose; Gibco) supplemented with 10% fetal bovine serum and 1% gentamycin. Myogenic differentiation into myotubes was induced when cells reached 80% confluency by adding DMEM supplemented with 2% horse serum (HS) and 1% gentamycin at 37 °C in a humidified incubator under 5% CO~2~ during 2 to 5 days. When indicated, we added SR9009 or SR9011 (5 μM) to the medium one day prior to differentiation and for the length of the differentiation period (8 days).

Serum shock {#S14}
-----------

We assessed circadian gene expression patterns in cells after synchronization by a 2-h horse serum shock on near confluent cells ^[@R40]^. After 2 h, the medium was changed to 2% serum-containing medium as above.

Retroviral production and infection {#S15}
-----------------------------------

We cultured Phoenix Eco cells (Orbigen) in DMEM containing 10% fetal bovine serum, and 1% gentamycin at 37 °C under standard culture conditions. To generate cell lines constitutively over-expressing Rev-erb-α, we inserted the coding sequence of human *Reverbα* in the pBabe retrovirus plasmid (Addgene) using the BamHI-SalII sites to generate pBabe-Rev-erb-α (Rev-erbα). We used the empty vector (pBabe) as control. To down-regulate *Rev-erbα* expression, we inserted the sh*Rev-erbα* sequence in psilencer 5.1-U6 Retro (Ambion) using the BamH1 and HindIII sites. Phoenix cells (100,000 per cm^2^) were transfected with the pBabe plasmid constructs (20 μg) using the cationic lipid RPR 120535B as previously described^[@R41]^. C2C12 cells were infected with the supernatant from pBabe or pBabe-Rev-erbα and shControl (shCTL) or sh*Rev-erbα*, and puromycin-resistant infected cells were used within 15 days after infection. We verified *Rev-erbα* over-expression by RT-qPCR on Rev-erb-α C2C12 cells compared to pBabe control cells ([Fig. S8b](#SD1){ref-type="supplementary-material"}). We verified Rev-erb-α nuclear localization by western blot analysis ([Fig. S8c](#SD1){ref-type="supplementary-material"}), and we verified its repressive transcriptional activity by transient transfection on a consensus RevDR2 site in Rev-erbα vs pBabe C2C12 cells and compared to non-infected C2C12 cells after co-transfection of a pSG5Rev-erbα expression plasmid ([Fig. S8d](#SD1){ref-type="supplementary-material"}). *Rev-erbα* down-regulation was verified by qPCR analysis of *Rev-erbα* mRNA on sh*Rev-erbα* C2C12 cells vs. control cells ([Fig. S8e](#SD1){ref-type="supplementary-material"}).

Determination of cellular respiration {#S16}
-------------------------------------

C2C12 cells (1 × 10^6^ cells ml^−1^) suspended in cell culture media (RPMI + 10% FCS) were placed into the chambers of the O2K oxygraph, operating at 37 °C. Routine respiration (R) was measured 20 min later. Then, 2 μg ml^−1^ oligomycin was injected into the chambers to obtain the oligomycin-inhibited leak rate of respiration (4o, Leak, 'L'), ie. uncoupled respiration. Finally, pulses of FCCP (1 μM) were added into the chambers until maximal oxygen consumption was reached (3u, OXPHOS, 'P'). It represents the maximal respiratory capacity. The respiratory control ratio (RCR), i.e. the coupled oxidative phosphorylation, is expressed as 3u/4o ratio.

Oxygen consumption on permeabilized soleus fibers {#S17}
-------------------------------------------------

After cervical dislocation, soleus or tibialis anterior muscles were excised and placed into a Petri dish containing ice-cold biopsy preservation solution (BIOPS) and permeabilized fibers were prepared as previously described ^[@R42]^. We placed fibers (3 to 6 mg wet weight) into the O2K oxygraph chambers (Oroboros Instruments, Innsbruck, Austria). In the first chamber, we added glutamate (10 mM) and malate (2 mM) to obtain state 2 respiration. Then, we injected 2.5 mM ADP into the chamber to measure ADP-coupled oxygen consumption (state 3). Further addition of succinate (10 mM) allowed estimation of the entire OXPHOS capacity. Finally, complex I and III were inhibited with rotenone (0.5 μM) and antimycin A (2.5 μM), respectively. In the second chamber, we added palmitoyl-carnitine (5 or 20 μM) and malate (2 mM). After stabilization, coupled respiration was obtained with 2.5 mM ADP. Addition of exogenous cytochrome c (10 μM) was done in all experiments in order to test external membrane integrity. Experiments were performed at 25 °C.

Muscle mitochondria isolation {#S18}
-----------------------------

We cut muscles into small pieces and placed them into a Trypsin-EDTA solution for 15 min at 4 °C. Samples were rinsed with mitochondrial isolation buffer (in mM: sucrose 300, TES 5, EGTA 0.2, pH 7.2) and homogenized with a glass tissue grinder. After centrifugation at 800 g for 7 min, supernatant was collected and spun twice at 8,800 g. The final mitochondrial pellet was suspended into respiration medium Mitomed2 and mitochondria (150 μg) were placed into the oxygraph chambers. Substrates and protocols were as described for permeabilized fiber respiration.

Mitochondria quantity and function Quantification of mtDNA copy number {#S19}
----------------------------------------------------------------------

We isolated mitochondrial DNA (mtDNA) from murine muscles after digestion with Proteinase K (100 μg ml^−1^) by phenol/chloroform extraction. Relative amounts of nuclear DNA and mtDNA were determined by quantitative real-time PCR. We selected *NADH dehydrogenase 1* gene for quantification of mtDNA and *ppia* (also known as *cyclophilin*) for nuclear DNA quantification.

Mitotracker-FACS quantification {#S20}
-------------------------------

Rev-erb-α over-expressing, sh*Rev-erbα* cells and their respective control cells were washed with PBS, trypsinized and incubated at 37 °C for 20 min with 100 nM MitoTracker Green FM and Red FM dyes (Molecular Probes). Mitotracker Green probe preferentially accumulates in mitochondria, allowing estimation of mitochondrial quantity. Mitotracker Red probe is a red-fluorescent dye that stains mitochondria in living cells and its accumulation is dependent on the membrane potential (Molecular Probes). Samples were washed 3 times in PBS and subjected to flow cytometric analysis on a FACSCalibur apparatus (Becton Dickinson, San Jose, CA).

ATP assay {#S21}
---------

We measured ATP concentrations using a commercially available kit (EnzyLight^™^ ATP Assay Kit, Bioassay Systems, Hayward, CA, USA) following the manufacturer's instructions.

NAD assay {#S22}
---------

We measured NAD+ and NADH concentrations using a commercially available kit (Biovision Research Products, Mountain View, CA, USA) following the manufacturer's instructions.

Quantitative RT-QPCR {#S23}
--------------------

We isolated total RNA from tissues by guanidinium thiocyanate/phenol/chloroform extraction^[@R43]^ and from C2C12 cells using the Trizol reagent (Invitrogen). Isolated RNA was reverse transcribed into cDNA using commercially available reagents (Superscript II kit; Applied Bioscience). We performed quantitative PCR (qPCR) with the Brilliant III SYBR Green QPCR Master Mix (Agilent) and specific primers following manufacturer's instructions and using a mx3005 apparatus (Agilent). Gene expression was normalized to cyclophillin and expressed as indicated in the legends to figures. A list of specific primers is available in [Supplementary Table 1](#SD1){ref-type="supplementary-material"}.

Antibodies and immunoblotting {#S24}
-----------------------------

Protein extracted from muscle biopsies or cells were separated by SDS-polyacrylamide gel electrophoresis and we performed immunoblot analyses according to standard procedures. Proteins were transferred onto PVDF membranes and immunoblot analyses were carried out using antibodies directed against p-AMPK (Thr172)(1:1,000, Cell Signaling technology 2535) and AMPK (1:1,000, Cell Signaling technology 2532), Ppargc1-α (1:500, Santa-cruz biotechnology, sc-13067), Gapdh (1:500, Santa-cruz biotechnology, sc-25778), Actin (1:1,000, Santa-cruz biotechnology sc-1616), Bnip3 and Map1lc3a (1:1,000, Abcam38621 and Abcam51520, respectively), Park2 (1:1,000, Millipore ab9244), Acac (1:1,000, Cell Signalling 3662), p-Acac (S79) (1:1,000, Cell Signalling 3661), OX-PHOS (1:1,000, MitoSciences InVitrogen, iv 458099), Rev-erb-α (1:1,000, Perseus Proteomix PP-A8740A-00) following the manufacturer's instructions.

Ppargc1-α acetylation assay {#S25}
---------------------------

We analyzed Ppargc1-α acetylation in quadriceps muscle by immunoprecipitation of Ppargc1-α from 500 μg of protein extract with anti-Ppargc1-α antibody (Santa Cruz, sc-13067, 2 μg per sample) followed by western blot analysis using an acetyl-lysine antibody (1:2,000, Cell Signaling 9441) antibody.

Electron microscopy analysis of muscle sections {#S26}
-----------------------------------------------

We examined ultrastructural muscle morphology using transmission electron microscopy. To this end, muscle tissue blocks were fixed in 2.5% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4). Post-fixation was performed in 1% OsO~4~ in 0.1 M cacodylate buffer (pH 7.4) supplemented with 1.5% K~4~\[Fe(CN)~6~\|. Subsequently samples were dehydrated and embedded in epon. Ultrathin sections were examined using a Philips CM100 electron microscope.

Immunofluorescence assay {#S27}
------------------------

Frozen cross sections of muscle were fixed with acetone and incubated with antibodies directed to CD31 (1:100, BD Biosciences, BD557355), Pax7 (1:20, Developmental Studies Hybridoma Bank, PAX7), fiber types (1:25, Developmental Studies Hybridoma Bank, A4.840), and laminin (1:50, Sigma L9393). After incubation with the appropriate fluorescent-labeled secondary antibodies (Goat anti-rabbit IgG AlexaFluor 555 for CD31, Goat anti-mouse IgG1 AlexaFluor488 for Pax7, Goat anti-rabbit IgG AlexaFluor350 for laminin and Goat Anti-mouse IgM AlexaFlur488 for A4.840, all from InVitrogen/Moleculr Probes) and DAPI-stain (30 nM, Invitrogen) for nuclei, sections were mounted in Mowiol. Images were captured with a Nikon E800 fluorescence microscope ^[@R44]^.

Flow cytometry Map1lc3a analysis {#S28}
--------------------------------

Rev-erb-α over-expressing and control cells were seeded in 6 well-plates and serum-starved in presence or in absence of Bafilomycin (50 nM) or NH~4~Cl (25 mM) overnight at 37 °C. Before staining with a Map1lc3a antibody (1:50, MBL International M152-3 clone 4E12), we fixed the cells with 4% paraformaldehyde for 15 min at room temperature, washed them in PBS and then permeabilized them with digitonin (100 μg ml^−1^) for 15 min at room temperature. Digitonin permeabilization allowed the extraction of the cytosolic form of Map1lc3a protein (Map1lc3a--I) and the specific detection of the Map1lc3a--membrane-associated fraction (Map1lc3a--II), which correlates with the number of autophagosomes ^[@R45]^. Cells were finally incubated with alexa-488 conjugated anti-mouse IgG for 15 min (1:200, invitrogen, A11001). We acquired sample signals using FACSCalibur (Becton Dickinson, San Jose, CA) and analyzed them using FlowJo software (Tree Star).

Chromatin Immunoprecipitation (ChIP) {#S29}
------------------------------------

We performed ChIP-qPCR experiments as previously described ^[@R38]^ with minor changes as follows. Differentiated C2C12 cells infected with the Rev-erb-α or control (pBabe) retrovirus were cross-linked in 1% formaldehyde for 10min at room temperature. Nuclear extracts were prepared and the chromatin was sonicated for 15 min using the Bioruptor (Diagenode). Chromatins were immunoprecipitated over-night at 4 °C with either a Rev-erbα antibody (Cell Signaling Technology, 2124), a H3K9Ac antibody (Millipore, 17-658), or a H3K27Ac antibody (AbCam, ab4729), all at 3 μg per sample, and then incubated for 4 h at 4 °C with protein A and protein G Dynal magnetic beads (Dynal Biotech, Norway) and tRNA (10 μg ml^−1^). Cross-linking was reversed overnight at 65 °C. DNA was purified using the QIAquick PCR purification kit (Qiagen) and was analyzed by quantitative PCR using the Brilliant III SYBR Green QPCR Master Mix (Agilent) using specific primers ([Supplementary Table 2](#SD1){ref-type="supplementary-material"}).

Statistical Analysis {#S30}
--------------------

Values are means ± sem of the indicated number of measurements. Statistical significance was determined using two-tailed unpaired Student's t test with a significance level of 0.05 or Log-rank Mantel cox test.
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![*Rev-erb*α-deficient mice display reduced voluntary activity and exercise performance\
(**a**) Western blot analysis of mouse muscles; actin was used as control. Qua, quadriceps; Sol, soleus; Gas, gastrocnemius; EDL, extensor digitorum longus; Dia, diaphragm; TA, tibialis anterior (*n* = 7 per group). (**b**) Wheel voluntary activity of *Rev-erbα*^−/−^ mice compared to *Rev-erbα*^+/+^ mice (*n* = 5 per genotype). (**c**) Basal (at rest) and maximal aerobic capacity (VO~2~) during a progressive treadmill test to exhaustion in an enclosed single lane treadmill (*n* = 9--10 per genotype). (**d**) Endurance capacity of *Rev-erbα^−/−^* mice compared to *Rev-erbα*^+/+^ mice (*n* = 6 per genotype). (**e--f**) Running time (e) and distance (f) until exhaustion in endurance exercise (*n* = 6 per genotype). Results are expressed as means ± sem; \**P* \< 0.05, \*\*\**P* \< 0.001 by unpaired t-test (a--c,e--f) and by log-rank Mantel cox (d).](nihms472510f1){#F1}

![Rev-erb-α modulates mitochondria content and function\
(**a**) Mitochondrial DNA (mtDNA) content (*n* = 6 per genotype). (**b**) RT-qPCR analysis of mitochondrial respiratory chain subunit genes in soleus muscle (*n* = 7 per genotype). (**c**) Western blot analysis of mitochondrial complexes in soleus from Rev-erbα^−/−^ and *Rev-erbα*^+/+^ mice (*n* = 4--5 per genotype). (**d**) Mitochondrial respiration in permeabilized soleus fiber from *Rev-erb*α^−/−^ and *Rev-erb*α^+/+^ mice (Succ, succinate; Rot, rotenone) (*n* = 7 per genotype). (**e**) Mitochondrial respiration from isolated muscle mitochondria (*n* = 5 per genotype). (**f**) Mitochondrial fatty acid β-oxidation-dependent respiration in isolated permeabilized soleus fibers from *Rev-erb*α^−/−^ and Rev-erbα^+/+^ mice (*n* = 6 per genotype). (**g**) Skeletal muscle (soleus) expression of genes encoding proteins involved in fatty acid oxidation (*n* = 7 per genotype). (**h**) Electron microscopy analysis of *Rev-erb*α^−/−^ and Rev-erbα^+/+^ muscle. Black arrows: swollen, less dense mitochondria; white arrowheads: normal mitochondria. Representative pictures from *n* = 5 mice per genotype. Results are expressed as means ± sem; \**P* \< 0.05 and \*\**P* \< 0.01, by unpaired t-test.](nihms472510f2){#F2}

![Rev-erb-α modulates mitochondrial respiration\
(**a**) Mitochondria content in Rev-erb-α-expressing (Rev-erbα) or control (pBabe) retrovirus infected C2C12 cells by flow cytometry analysis of green mitotracker (MT) staining (Left, representative histogram; Right, mean fluorescence intensity (MFI)) (*n* = 6 per condition). (**b**) Functional mitochondria content by flow cytometry analysis of JC--1 (Left) and JC1red/JC1green (i.e. high/low mitochondrial membrane potential) MFI ratio (Right) (*n* = 6 per condition). (**c**) Oxygen consumption in Rev-erbα and control pBabe cells (*n* = 5 per condition). (**d**) RT-qPCR analysis of fatty acid oxidation gene expression in differentiated C2C12 cells infected with Rev-erbα or control (pBabe) retrovirus (*n* = 6 per group). Results are expressed as means ± sem; \**P* \< 0.05, \*\*\* *P* \< 0.001 by unpaired t-test.](nihms472510f3){#F3}

![Rev-erb-α modulates mitochondrial biogenesis by interfering with Ampk-Sirt1-Ppargc1-α signaling\
(**a--g**) Soleus Ppargc1-α protein relative amounts (**a**), mRNA concentrations of *Tfam* and *Nuclear respiratory factor 1* (*Nrf1)* (**b**), cellular ATP concentrations (**c**), *Stk11* mRNA concentrations (**d**), western blot analysis of Ampk phosphorylation (**e**), *Nampt* and *Sirt1* mRNA concentrations (**f**), NAD+ and NADH cellular concentrations, (**g**) acetylated Ppargc1-α protein relative amounts in *Rev-erb*α^−/−^ and Rev-erbα^+/+^ soleus muscle (*n* = 7 per genotype). (**h**) *Ppargc1*α*, Tfam*, *Sirt1* and *Nampt* gene expression in Rev-erb-α (Rev-erbα) vs. control (pBabe) retrovirus infected C2C12 cells (*n* = 6 per group). (**i**) OXPHOS (3U) mitochondrial respiration and RCR in absence or presence of the Ampk phosphorylation inhibitor C compound (CC) in C2C12 cells infected with Rev-erb-α or control (pBabe) retrovirus. (*n* = 6 per condition) (**j**) Mitochondria content in Rev-erb-α-expressing (Rev-erbα) or control (pBabe) retrovirus infected C2C12 cells transfected with a siRNA to reduce *Ampkα1* and *Ampkα2* expression or a scramble control siRNA: green Mitotracker mean fluorescence intensity (MFI) (*n* = 3 per condition). Results are expressed as means ± sem \**P* \< 0.05, \*\**P* \< 0.01, and \*\*\**P* \< 0.001, ^§§^P \< 0.01by unpaired t-test.](nihms472510f4){#F4}

![Rev-erb-α modulates skeletal muscle autophagy\
(**a**) RT-qPCR analysis of autophagy gene expression in soleus from *Rev-erb*α^−/−^ and Reverbα^+/+^ littermates. (*n* = 7 per genotype). (**b**) Western blot analysis of soleus muscle Park2 and Bnip3 proteins in *Rev-erb*α^−/−^ mice compared to Rev-erbα^+/+^ littermates. (**c**) Western blot analysis of Map1lc3a--I and Map1lc3a--II protein in soleus from Rev-erbα^−/−^ and Rev-erbα^+/+^ mice (*n* = 3--4 per genotype). (**d**) Flow cytometry delta (treated -- vehicle) mean fluorescence intensity (MFI) of Map1lc3a--II protein levels in C2C12 cells infected with Rev-erbα (Reverbα) vs control (pBabe) retrovirus and treated with lysosome inhibitors (50 nM bafilomycin or 25 mM NH~4~Cl) or their respective vehicle after 16 h serum deprivation (*n* = 6 per condition). (**e**) Mitochondria content in sh*Rev-erb*α and control (shCTL) cells treated or not with 5 mM 3-methyl adenine (3MA) or 50 μM chloroquine (CQ) or 100 nM bafilomycin or 25 mM NH~4~Cl: specific green mitotracker (MT) flow cytometry MFI (*n* = 6 per condition). (**f**) Rev-erb-α binding to regulatory regions of the indicated autophagy genes measured by ChIP-qPCR (*n* = 3 independent experiments). (**g--h**) ChIP-qPCR examining the Rev-erb-α binding regions from (**e**) for changes in H3K27 and H3K9 acetylation (*n* = 3 independent experiments). (**f--h**) ChiP experiments were conducted on Rev-erb-α over-expressing (Rev-erbα) and control (pBabe) C2C12 cells. Results are expressed as means ± sem \**P* \< 0.05, \*\**P* \< 0.01 and \*\*\**P* \< 0.001, by unpaired t-test.](nihms472510f5){#F5}

![Rev-erb-α over-expression or pharmacological activity improves mitochondrial function and exercise capacity\
(**a**) Running distance and time until exhaustion in endurance exercise in mice treated with SR9009 (100 mpk for 30 days) (*n* = 6 per group). (**b**) Mitochondria content in C2C12 cells treated with SR9009 (5 μM), SR9011 (5 μM) or vehicle: representative bargraph of flow cytometry green mitotracker (upper panel) and red mitotracker (bottom panel) staining (*n* = 4 per condition). (**c**) Mitochondrial respiration in permeabilized fiber isolated from tibialis anterior muscle from mice intra-muscularly injected with a Rev-erb-α expressing AAV vector (*n* = 4 per group). Results are expressed as means ± sem; \**P* \< 0.05, \*\**P* \< 0.01 by unpaired t-test.](nihms472510f6){#F6}
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